A Proteomic-Based Workflow Using Purified Respiratory Syncytial Virus Particles to Identify Cellular Factors as Drug

Tra Nguyen Huong1, Boon Huan Tan2, Richard J Sugrue3

  • 1School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore, 637551, Singapore.

Insights

Identifying host cell proteins is key to finding new drugs against respiratory syncytial virus (RSV). This study found that HSP90 is crucial for RSV replication, suggesting it as a potential drug target.

Area of Science:

  • Virology
  • Proteomics
  • Drug Discovery

Background:

  • Respiratory syncytial virus (RSV) replication relies on host cell factors.
  • Identifying essential cellular proteins can reveal druggable targets for antiviral therapies.

Purpose of the Study:

  • To identify cellular proteins associated with purified RSV particles using proteomics.
  • To investigate the role of identified host factors, particularly HSP90, in RSV replication.

Main Methods:

  • Purification of RSV particles from infected cells.
  • Proteomic analysis to characterize the protein composition of purified RSV.
  • Validation of HSP90's role using imaging, gene silencing, and small molecule inhibitors.

Main Results:

  • Proteomic analysis identified actin, actin-binding proteins, HSP70, and HSP90 co-purifying with RSV particles.
  • HSP90 was confirmed to be relevant for RSV replication through experimental validation.

Conclusions:

  • Host cell chaperones, specifically HSP90, are associated with purified RSV particles.
  • HSP90 is a critical factor for RSV replication and represents a potential therapeutic target.